Report
GlobalData Healthcare Department
EUR 115.88 For Business Accounts Only

Macquarie Infrastructure and Real Assets Fund - Company Review

Macquarie Infrastructure and Real Assets Fund - Company Review

Summary

Macquarie Infrastructure and Real Assets Fund (MIRA) is an infrastructure asset management company. The firm’s clients include institutional investors such as global pension and superannuation funds and other institutions and governments. The firm focuses on investing in sectors such as infrastructure, agriculture, real estate, utilities, communications, energy and insurance, through a wide range of private and public funds. The firm has investments in Brussels Airport, Arqiva Broadcast Holdings Limited, GMR airports, Hanjin Pacific Corporation, Axiom Group, and Cleco Corporation. It operates in London, New York, Hong Kong, Sydney and Seoul. MIRA is an infrastructure investment arm of Macquarie Asset Management division, which offers diverse investment services such as infrastructure and real assets management, securities investment management and specialized investment solutions to institutional and retail investors. MIRA have around US$105 billion of assets under management as of 31 March 2016. MIRA is headquartered in Sydney, Australia.

This comprehensive company report of Macquarie Infrastructure and Real Assets Fund provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Provider
GlobalData Plc
GlobalData Plc

​GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.

Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.

Analysts
GlobalData Healthcare Department

Other Reports from GlobalData Plc

ResearchPool Subscriptions

Get the most out of your insights

Get in touch